Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Aphria Inc.

Start price
Target price
Perf. (%)
€8.65
15.02.19
€10.00
13.03.19
-2.31%
13.03.19

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Medicines Co.

Start price
Target price
Perf. (%)
€20.80
01.02.19
€24.81
12.03.19
13.57%
12.03.19

buy
Acceleron Pharma Inc.

Start price
Target price
Perf. (%)
€37.68
04.03.18
€55.92
04.03.19
9.98%
04.03.19

buy
Aphria Inc.

Start price
Target price
Perf. (%)
€6.14
24.01.19
€10.00
05.02.19
63.36%
05.02.19

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Pra Health

Start price
Target price
Perf. (%)
€89.79
20.01.19
€95.16
31.01.19
5.98%
31.01.19

buy
Viatris Inc.

Start price
Target price
Perf. (%)
€26.37
12.01.19
€27.24
30.01.19
5.28%
30.01.19

buy
Acceleron Pharma Inc.

Start price
Target price
Perf. (%)
€43.31
12.12.18
€48.71
22.01.19
-15.06%
22.01.19

buy
Aphria Inc.

Start price
Target price
Perf. (%)
€5.59
11.01.19
€7.00
16.01.19
7.16%
16.01.19

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€5.02
28.12.18
€7.00
02.01.19
0.00%
02.01.19

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€5.05
27.12.18
€10.00
27.12.18
-0.99%
27.12.18

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Viatris Inc.

Start price
Target price
Perf. (%)
€36.79
07.06.18
€38.79
07.12.18
-23.56%
07.12.18

buy
Myokardia Inc

Start price
Target price
Perf. (%)
€51.22
16.10.18
€57.73
08.11.18
13.07%
08.11.18

buy
Nektar Therapeutics

Start price
Target price
Perf. (%)
€75.16
16.05.18
€90.20
08.11.18
-56.56%
08.11.18

buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€51.42
24.01.18
€86.41
01.11.18
-5.41%
01.11.18

buy
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€40.27
11.10.18
€45.55
31.10.18
13.69%
31.10.18

buy
Opko Health Inc.

Start price
Target price
Perf. (%)
€2.98
28.09.18
€3.88
18.10.18
12.41%
18.10.18

buy
Aphria Inc.

Start price
Target price
Perf. (%)
€10.87
08.10.18
€18.00
17.10.18
14.54%
17.10.18

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Myokardia Inc

Start price
Target price
Perf. (%)
€47.21
12.10.18
€51.41
16.10.18
8.98%
16.10.18

buy
QiAGen

Start price
Target price
Perf. (%)
€26.31
16.11.17
€35.00
12.10.18
2.15%
12.10.18

buy
United Therapeutics

Start price
Target price
Perf. (%)
€121.14
21.02.18
€125.38
21.08.18
-6.90%
21.08.18

buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€27.73
25.06.18
€35.00
15.08.18
-4.00%
15.08.18

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Known brand
buy
Evotec SE

Start price
Target price
Perf. (%)
€13.59
18.01.18
€19.00
18.07.18
20.60%
18.07.18

buy
Ligand Pharmaceuticals

Start price
Target price
Perf. (%)
€172.55
15.06.18
€189.42
06.07.18
13.25%
06.07.18

buy
Aphria Inc.

Start price
Target price
Perf. (%)
€8.28
24.06.18
€15.00
28.06.18
-8.57%
28.06.18

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
BB Biotech AG

Start price
Target price
Perf. (%)
€57.58
20.10.17
€70.00
20.04.18
0.59%
20.04.18